Back to Psychiatry
Psychiatryv1979Evidence-Based

Montgomery-Asberg Depression Rating Scale (MADRS)

Stratifies severity of depressive episodes in adults using 10 core mood symptoms, particularly sensitive to treatment-induced changes.

Clinical Input Parameters

points
Range: 0 — 6 points
points
Range: 0 — 6 points
points
Range: 0 — 6 points
points
Range: 0 — 6 points
points
Range: 0 — 6 points
points
Range: 0 — 6 points
points
Range: 0 — 6 points
points
Range: 0 — 6 points
points
Range: 0 — 6 points
points
Range: 0 — 6 points
Clinical Assessment
Awaiting Parameters
madrs score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Montgomery-Asberg Depression Rating Scale (MADRS) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within psychiatry.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

MADRS Score = Sum of all 10 items (each scored 0-6). Range: 0-60 points. Severity: Normal (0-6), Mild (7-19), Moderate (20-34), Severe (35-60).

Clinical Pearls & Practice Notes

  • Designed to be sensitive to changes from antidepressant treatment
  • More sensitive to treatment-induced changes than Hamilton Depression Rating Scale
  • Each item scored 0-6: 0 = normal/absent, 6 = severe/continuous presence
  • Response to treatment defined as ≥50% reduction from baseline
  • Remission typically defined as score ≤7-9 points
  • Clinically meaningful change: ≥6 points improvement
  • Clinically substantial change: ≥12 points improvement
  • Screening tool, not diagnostic - supplements clinical assessment
  • Focus on core mood symptoms rather than somatic symptoms
  • Widely used in clinical trials and practice for depression assessment

Evidence & Literature Citations

  1. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-9. doi: 10.1192/bjp.134.4.382.
  2. Snaith RP, Harrop FM, Newby DA, Teale C. Grade scores of the Montgomery-Asberg Depression and the Clinical Anxiety Scales. Br J Psychiatry. 1986;148:599-601. doi: 10.1192/bjp.148.5.599.
  3. Turkoz I, Alphs L, Singh J, Jamieson C, Daly E, Shawi M, et al. Clinically meaningful changes on depressive symptom measures and patient-reported outcomes in patients with treatment-resistant depression. J Affect Disord. 2021;281:267-273. doi: 10.1016/j.jad.2020.12.021.

Score Interpretation Ranges

Normal0 – 6 pts

No or minimal depression

Mild Depression7 – 19 pts

Mild depressive symptoms

Moderate Depression20 – 34 pts

Moderate depressive symptoms

Severe Depression35 – 60 pts

Severe depressive symptoms

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.